Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers

NCT07743593 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07743593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07743593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 5, 2027
Completion date
August 30, 2031
Enrollment
505 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryptococcal antigenemia, cryptococcal infection, cryptococcal meningitis, hiv-1-infection